Pravastatin Reduces Acute Phase Response of Zoledronic Acid

Condition:   Postmenopausal Osteoporosis Interventions:   Drug: Pravastatin Sodium 80 MG;   Drug: Placebo Sponsor:   Peking University Third Hospital Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials